864
Participants
Start Date
May 20, 2020
Primary Completion Date
December 20, 2026
Study Completion Date
April 20, 2027
"Intra-operative single intravenous(iv) dose of cephalexin 2 g or clindamycin 900 mg."
Treatment Arm A
"Intra-operative single dose (iv) of cephalexin 2 g or clindamycin 900 mg and postoperative oral dose of cephalexin 250mg (every 4 hours) or clindamycin 150mg(every 6 hours) for 3 days"
Treatment Arm B
Facial Plastic and Reconstructive Surgery Clinic, Stanford
Collaborators (1)
Washington University School of Medicine
OTHER
Vanderbilt University School of Medicine
OTHER
University of Washington
OTHER
Duke University
OTHER
Harvard University
OTHER
University of Kansas Medical Center
OTHER
University of Cincinnati
OTHER
Loma Linda University
OTHER
Stanford University
OTHER